Nonetheless, blocking TNF-α has served as a successful therapeutic target for asthma patients on corticosteroid treatment, while LTA facilitates the attachment of lymphotoxin β to the cell surface by forming heterotrimers with it when released into extracellular space [45,46]. This evidence concerns the gene TNF and asthma.